Global Plasma Fractionation Market Size To Worth USD 51.8 Billion by 2032 | CAGR of 6.7%
Category: HealthcareGlobal Plasma Fractionation Market Size To Worth USD 51.8 Billion by 2032
According to a research report published by Spherical Insights & Consulting, the Global Plasma Fractionation Market Size is to Grow from USD 27.1 Billion in 2022 to USD 51.8 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 6.7% during the projected period. Because of rising demand for plasma-derived therapies, advancements in fractionation technology, and increased awareness of these treatments, the global plasma fractionation market has grown significantly in recent years.
Get more details on this report -
Browse key industry insights spread across 200 pages with 130 market data tables and figures & charts from the report on "Global Plasma Fractionation Market Size, Share, and COVID-19 Impact Analysis, By Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), By Application (Neurology, Immunology, Hematology, Rheumatology), By End User (Clinical Research, Hospitals & Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/plasma-fractionation-market
The worldwide plasma fractionation market refers to the rapidly expanding healthcare business that separates and purifies blood plasma components for medicinal and diagnostic applications. Blood plasma, the liquid part of blood, includes important proteins and antibodies that are necessary for many medical treatments. The technique of isolating and concentrating these useful components so that they can be used to treat a range of medical problems is known as plasma fractionation. The increasing incidence of older people around the world, who are more vulnerable to rare conditions that demand the use of blood derivatives, is a major driver of market growth. Additionally, the rising use of immunoglobulins and alpha-1-antitrypsin in many disciplines of medicine around the world is likely to fuel market expansion. The expansion of blood collection facilities around the world is another major factor driving the growth of this market. Plasma collection centers, manufacturers, healthcare providers, and patients are among the many stakeholders in this market. As the global prevalence of chronic diseases rises, the global plasma fractionation market is positioned for continuous growth, providing hope and improved healthcare results for countless people. However, plasma-derived product manufacture is a time-consuming and costly process that requires numerous processes such as plasma collection, fractionation, and purification. These medicines may be costly due to high production costs, particularly in emerging markets.
The Immunoglobulins segment is expected to register significant growth rate in the global plasma fractionation market during the forecast period.
The global plasma fractionation market is divided into Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, and PCC. Among these, the Immunoglobulins segment is projected to grow rapidly in the global plasma fractionation market over the forecast period. Immunoglobulins have historically accounted for a sizable portion of the plasma fractionation market, owing to their widespread therapeutic applications and rising demand. They are used to treat a wide range of immune deficiencies, autoimmune diseases, and neurological disorders.
The neurology segment accounted for the largest share of the global plasma fractionation market in 2022.
The global plasma fractionation market is segmented by application into Neurology, Immunology, Hematology, and Rheumatology. The neurology segment held the largest share of the global plasma fractionation market in 2022. The neurology segment is significant due to the rising prevalence of neurological disorders and the expanding applications of IVIG in this field.
North America is anticipated to hold a significant share of the global plasma fractionation market over the predicted timeframe.
Get more details on this report -
North America has long been a major player in the global plasma fractionation market. The United States, in particular, plays a critical role due to its advanced healthcare infrastructure, high disease prevalence, and strong presence of major plasma product manufacturers.
During the forecast period, Asia Pacific is projected to expand at the fastest rate in the global plasma fractionation market. Due to factors such as a large patient population, rising healthcare expenditure, and increased awareness of plasma-derived therapies, the Asia-Pacific region has grown heavily in recent years. China and India are emerging as major players in this market.
Major vendors in the Global Plasma Fractionation Market include CSL, Takeda Pharmaceutical company limited, Grifols, S.A., Octapharma AG, Kedrion S.P.A, LFB, ADMA Biologics, Sanquin, China Biologic Products Holdings Inc., GC Pharma, Hualan Bioengineering Co., Ltd., Japan Blood Products Organization, Emergent BioSolutions, Shanghai Raas Blood Products Co., Ltd., and Others.
Recent Developments
- In April 2023, CSL (Australia) received FDA approval for the 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid) for patients with PI and CIPD.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2032. Spherical Insights has segmented the Global Plasma Fractionation Market based on the below-mentioned segments:
Global Plasma Fractionation Market, By Product
- Immunoglobulins
- Albumin
- Protease Inhibitors
- von Willebrand Factor
- PCC
Global Plasma Fractionation Market, By Application
- Neurology
- Immunology
- Hematology
- Rheumatology
Global Plasma Fractionation Market, By End User
- Clinical Research
- Hospitals & Clinics
Global Plasma Fractionation Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?